Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954

This publication has 21 references indexed in Scilit:

• Physical characterisation of the Escherichia coli B gene encoding nitroreductase and its over-expression in Escherichia coli K12
  FEMS Microbiology Letters, 1994
• Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health
  Human Gene Therapy, 1993
• The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—II: A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase
  Biochemical Pharmacology, 1992
• The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I
  Biochemical Pharmacology, 1992
• In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors
  Science, 1992
• The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide)
  Biochemical Pharmacology, 1991
• The nitroreductase enzyme in walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
  Biochemical Pharmacology, 1988
• A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in walker carcinoma cells
  Biochemical Pharmacology, 1988
• Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
  Cell, 1986
• Tumour-growth inhibitorynitrofphenylaziridines and related compounds structure-activity relationships
  Chemico-Biological Interactions, 1969